Healthcare provider profile · identity verified

Kyla N Pepper, MD

Family Practice · SALEM, OR · NPI 1578786778

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	478	141
Levothyroxine Sodium	Levothyroxine Sodium	419	105
Losartan Potassium	Losartan Potassium	378	114
Lisinopril	Lisinopril	352	117
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	307	100
Amlodipine Besylate	Amlodipine Besylate	303	100
Gabapentin	Gabapentin	246	83
Rosuvastatin Calcium	Rosuvastatin Calcium	235	70
Oxycodone Hcl	Oxycodone Hcl	213	76
Simvastatin	Simvastatin	205	60
Atenolol	Atenolol	196	60
Albuterol Sulfate Hfa	Albuterol Sulfate	188	80
Furosemide	Furosemide	187	58
Trazodone Hcl	Trazodone Hcl	187	61
Metformin Hcl	Metformin Hcl	179	59
Pantoprazole Sodium	Pantoprazole Sodium	155	63
Pradaxa	Dabigatran Etexilate Mesylate	147	46
Omeprazole	Omeprazole	145	47
Potassium Chloride	Potassium Chloride	145	50
Metoprolol Tartrate	Metoprolol Tartrate	139	42
Metoprolol Succinate	Metoprolol Succinate	137	43
Sertraline Hcl	Sertraline Hcl	130	41
Alendronate Sodium	Alendronate Sodium	127	42
Hydrochlorothiazide	Hydrochlorothiazide	126	42
Duloxetine Hcl	Duloxetine Hcl	125	34
Meloxicam	Meloxicam	116	49
Pravastatin Sodium	Pravastatin Sodium	103	25
Metformin Hcl Er	Metformin Hcl	98	37
Tamsulosin Hcl	Tamsulosin Hcl	90	35
Wixela Inhub	Fluticasone Propion/Salmeterol	86	25
Citalopram Hbr	Citalopram Hydrobromide	83	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	83	26
Lorazepam	Lorazepam	80	36
Spironolactone	Spironolactone	79	26
Zolpidem Tartrate	Zolpidem Tartrate	78	12
Finasteride	Finasteride	75	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	73	24
Ondansetron Odt	Ondansetron	72	22
Tramadol Hcl	Tramadol Hcl	71	27
Fluoxetine Hcl	Fluoxetine Hcl	70	27
Spiriva Respimat	Tiotropium Bromide	70	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	69	22
Prednisone	Prednisone	69	40
Alvesco	Ciclesonide	68	23
Bupropion Xl	Bupropion Hcl	65	22
Mirtazapine	Mirtazapine	63	22
Triamcinolone Acetonide	Triamcinolone Acetonide	62	34
Carvedilol	Carvedilol	61	20
Glipizide	Glipizide	60	20
Estradiol	Estradiol	58	33
Memantine Hcl	Memantine Hcl	57	14
Escitalopram Oxalate	Escitalopram Oxalate	56	22
Alprazolam	Alprazolam	55	14
Venlafaxine Hcl Er	Venlafaxine Hcl	55	21
Fluticasone Propionate	Fluticasone Propionate	54	20
Allopurinol	Allopurinol	51	18
Ozempic	Semaglutide	50	suppressed
Propranolol Hcl	Propranolol Hcl	49	13
Warfarin Sodium	Warfarin Sodium	49	12
Buspirone Hcl	Buspirone Hcl	45	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	21
Ibuprofen	Ibuprofen	43	20
Montelukast Sodium	Montelukast Sodium	43	16
Ropinirole Hcl	Ropinirole Hcl	42	11
Baclofen	Baclofen	41	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	40	11
Shingrix	Varicella-Zoster Ge/As01b/Pf	40	37
Donepezil Hcl	Donepezil Hcl	38	12
Morphine Sulfate	Morphine Sulfate	38	suppressed
Eliquis	Apixaban	37	13
Humulin N	Insulin Nph Human Isophane	37	13
Morphine Sulfate Er	Morphine Sulfate	37	suppressed
Trospium Chloride	Trospium Chloride	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Terazosin Hcl	Terazosin Hcl	34	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	34	11
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Valsartan	Valsartan	32	14
Jardiance	Empagliflozin	31	11
Pregabalin	Pregabalin	31	20
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Hydrocortisone	Hydrocortisone	29	13
Methocarbamol	Methocarbamol	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Famotidine	Famotidine	28	15
Acyclovir	Acyclovir	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	26
Ipratropium Bromide	Ipratropium Bromide	26	11
Naproxen	Naproxen	26	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	25	suppressed
Torsemide	Torsemide	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Nitroglycerin	Nitroglycerin	23	12
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Topiramate	Topiramate	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Cartia Xt	Diltiazem Hcl	21	14
Cephalexin	Cephalexin	21	16
Digoxin	Digoxin	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	16
Hydromorphone Hcl	Hydromorphone Hcl	21	suppressed
Nystatin	Nystatin	21	18
Acetaminophen-Codeine	Acetaminophen With Codeine	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	12
Azelastine Hcl	Azelastine Hcl	19	suppressed
Clonazepam	Clonazepam	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	11
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	17
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	18	18
Verapamil Er	Verapamil Hcl	18	suppressed
Carbamazepine	Carbamazepine	17	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	16	15
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Climara	Estradiol	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Oxazepam	Oxazepam	12	suppressed
Zolmitriptan Odt	Zolmitriptan	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error